Evidence map›Paper›PMID 40701970›Full record

ArticleNature communications2025

Macrophage-T cell interactions promote SLAMF1 expression for enhanced TB defense.

G V R Krishna Prasad, Steven J Grigsby, Gideon A Erkenswick, Cynthia Portal-Celhay, Ekansh Mittal, Guozhe Yang, Samuel M Fallon, Fengyixin Chen, Thais Klevorn, Neharika Jain and 5 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Targeting Latent Tuberculosis: Immunogenic Evaluation of aInternational journal of molecular sciences · 2026
    Article
  2. Article
  3. Article
  4. HowVaccines · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. iScience · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

G V R Krishna PrasadDivision of Infectious Diseases, Department of Medicine; Washington University School of Medicine, St. Louis, MO, USA.ORCID http://orcid.org/0000-0003-2698-4952
Steven J GrigsbyDivision of Infectious Diseases, Department of Medicine; Washington University School of Medicine, St. Louis, MO, USA.ORCID http://orcid.org/0000-0003-4701-7355
Gideon A ErkenswickDivision of Infectious Diseases, Department of Medicine; Washington University School of Medicine, St. Louis, MO, USA.ORCID http://orcid.org/0000-0001-6040-1170
Cynthia Portal-CelhayDivision of Infectious Diseases, Department of Medicine, New York University School of Medicine, New York, NY, USA.
Ekansh MittalDivision of Infectious Diseases, Department of Medicine; Washington University School of Medicine, St. Louis, MO, USA.ORCID http://orcid.org/0000-0001-9034-033X
Guozhe YangDivision of Infectious Diseases, Department of Medicine; Washington University School of Medicine, St. Louis, MO, USA.
Samuel M FallonDivision of Infectious Diseases, Department of Medicine; Washington University School of Medicine, St. Louis, MO, USA.
Fengyixin ChenDivision of Infectious Diseases, Department of Medicine; Washington University School of Medicine, St. Louis, MO, USA.
Thais KlevornDivision of Infectious Diseases, Department of Medicine, New York University School of Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0002-2765-1626
Neharika JainTufts University Cummings School of Veterinary Medicine, Department of Infectious Disease and Global Health, North Grafton, MA, USA.
Yuanyuan LiDivision of Infectious Diseases, Department of Medicine; Washington University School of Medicine, St. Louis, MO, USA.
Makedonka MitrevaDivision of Infectious Diseases, Department of Medicine; Washington University School of Medicine, St. Louis, MO, USA.ORCID http://orcid.org/0000-0001-9572-3436
Amanda J MartinotTufts University Cummings School of Veterinary Medicine, Department of Infectious Disease and Global Health, North Grafton, MA, USA.ORCID http://orcid.org/0000-0001-6237-6191
Joel D ErnstDivision of Experimental Medicine, University of California, San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0001-9951-6207
Jennifer A PhilipsDivision of Infectious Diseases, Department of Medicine; Washington University School of Medicine, St. Louis, MO, USA. philips.j.a@wustl.edu.ORCID http://orcid.org/0000-0002-9476-0240

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MARK Reid PHILIPS · 1985 to 2026
$83.1M
Initiation of the Immune Response to M. tuberculosisR01AI051242 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ERNST, JOEL D. · 2002 to 2019
$8.3M
Mechanisms of Innate Immune Evasion by Mycobacterium TuberculosisR01AI130454 · NIAID · WASHINGTON UNIVERSITY · PI JENNIFER A PHILIPS · 2017 to 2026
$5.9M
Understanding early macrophage-T cell interactions, SLAMF1, and immunity to TBR01AI184568 · NIAID · WASHINGTON UNIVERSITY · PI JENNIFER A PHILIPS · 2024 to 2026
$2.3M
High-Throughput TB Vaccine Antigen DiscoveryK08AI135098 · NIAID · TUFTS UNIVERSITY BOSTON · PI MARTINOT, AMANDA · 2018 to 2022
$931k
Molecular mechanism of T cell evasion by Mycobacterium tuberculosisK08AI119150 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PORTAL CELHAY, CYNTHIA · 2015 to 2018
$773k
The Role of SLAMF1 in TB ImmunityR21AI155380 · NIAID · WASHINGTON UNIVERSITY · PI PHILIPS, JENNIFER A · 2020 to 2021
$433k
Redox defenses and evasion of reactive oxygen species mediated host immunity in Mycobacterium tuberculosisF31AI152321 · NIAID · WASHINGTON UNIVERSITY · PI GRIGSBY, STEVEN JOSEPH · 2021 to 2023
$112k
NCI NIH HHS P30 CA016087NIAID NIH HHS F31 AI152321NIAID NIH HHS K08 AI119150NIAID NIH HHS K08 AI135098NIAID NIH HHS R01 AI051242NIAID NIH HHS R01 AI130454NIAID NIH HHS R01 AI184568NIAID NIH HHS R21 AI155380U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI051242U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI119150U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI130454U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI135098U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI152321U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI184568
6 · The paper itself

Abstract

CD4+ T cells are crucial for protective immunity to intracellular pathogens. In addition to secreting cytokines, CD4+ T cells promote control of Mycobacterium tuberculosis infection through cognate interactions with macrophages, but the mechanism has been unclear. Here, we show that SLAMF1/CD150 is highly and uniquely induced in macrophages by antigen-specific interactions with CD4+ T cells. In macrophages, SLAMF1 enhances the generation of reactive oxygen species and restricts Mtb replication. Mtb-infection of mice promotes SLAMF1 expression specifically on infected macrophages, not uninfected bystanders. SLAMF1 expression depends on adaptive immunity and also autophagy. Moreover, Slamf1

Indexed as

CD4-Positive T-LymphocytesMacrophagesMycobacterium tuberculosisSignaling Lymphocytic Activation Molecule Family Member 1TuberculosisAdaptive ImmunityAnimalsCell CommunicationFemaleHumansInterleukin-1betaMiceMice, Inbred C57BLMice, KnockoutInterleukin-1betaSignaling Lymphocytic Activation Molecule Family Member 1Slamf1 protein, mouse

Identifiers

PMID40701970
PMCPMC12287521

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.